VAN ANDEL INSTITUTE

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1996

Legal Domicile

Principal Officer

TIMOTHY J MYERS

Phone

6162345000

Tax Period

2023-12-01 to 2024-11-30

VAN ANDEL INSTITUTE, founded in 1996, is a major nonprofit in the Philanthropy & Grantmaking sector that reported $139.3M in total revenue in fiscal year 2023. Revenue decreased 19% compared to the prior year. The organization ran a surplus of $48.4M, a strong 35% operating margin.

Mission

VAN ANDEL INSTITUTE (VAI) IS ORGANIZED AND OPERATED FOR THE BENEFIT OF, TO PERFORM THE FUNCTIONS OF, OR TO CARRY OUT THE PURPOSES OF BOTH THE VAN ANDEL RESEARCH INSTITUTE (VARI) AND VAN ANDEL EDUCATION INSTITUTE (VAEI).

Program Service Accomplishments

Program 1

Expenses: $5,407,202

TO OPERATE FOR THE BENEFIT OF, TO PERFORM THE FUNCTIONS OF, OR TO CARRY OUT THE PURPOSES OF THE VAN ANDEL EDUCATION INSTITUTE (VAEI), WHICH INCLUDES THE VAN ANDEL INSTITUTE GRADUATE SCHOOL (VAIGS)...

TO OPERATE FOR THE BENEFIT OF, TO PERFORM THE FUNCTIONS OF, OR TO CARRY OUT THE PURPOSES OF THE VAN ANDEL EDUCATION INSTITUTE (VAEI), WHICH INCLUDES THE VAN ANDEL INSTITUTE GRADUATE SCHOOL (VAIGS) AND SCIENCE ACADEMY. VAIGS PREPARES BIOMEDICAL RESEARCH SCHOLARS THROUGH A GRADUATE PROGRAM IN CELL AND MOLECULAR GENETICS. THE SCIENCE ACADEMY PROGRAMS CREATE A UNIQUE SETTING FOR STUDENTS, K-12, ENCOURAGING AND ENABLING THEM TO EXPLORE, QUESTION, AND INVESTIGATE AS SCIENTISTS DO.

Program 2

Expenses: $61,431,822

TO OPERATE FOR THE BENEFIT OF, TO PERFORM THE FUNCTIONS OF, OR TO CARRY OUT THE PURPOSES OF THE VAN ANDEL RESEARCH INSTITUTE (VARI), A MEDICAL RESEARCH ORGANIZATION. VARI CONDUCTS BIOMEDICAL...

TO OPERATE FOR THE BENEFIT OF, TO PERFORM THE FUNCTIONS OF, OR TO CARRY OUT THE PURPOSES OF THE VAN ANDEL RESEARCH INSTITUTE (VARI), A MEDICAL RESEARCH ORGANIZATION. VARI CONDUCTS BIOMEDICAL RESEARCH, FOCUSING ON CANCER, EPIGENETICS, AND PARKINSON'S DISEASE, WITH AN EMPHASIS ON TRANSLATING SCIENTIFIC RESEARCH RESULTS INTO CLINICAL APPLICATIONS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $24,296,166

Program Service Revenue $0

Investment Income $115,094,054

Other Revenue $-57,446

TOTAL REVENUE $139,332,774

Expense Breakdown

Grants Paid $66,839,024

Salaries & Benefits $35,000

Fundraising Expenses $2,834,916

Program Expenses $66,839,024

Other Expenses $24,030,617

TOTAL EXPENSES $90,904,641

Year-over-Year Comparison

	2023	2022	Change
Revenue	$139,332,774	$171,827,012	-0.2%
Expenses	$90,904,641	$306,179,357	-0.7%
Net Income	$48,428,133	$-134,352,345	-1.4%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✓ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✓ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$2,122,812

Total Directors

$808,096

Key Employees

$1,216,274

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
DAVID VAN ANDEL	CHAIRMAN / CEO	10.00	Officer Director	$0	$108,088	$799,596
JOHN KENNEDY	TRUSTEE	1.00	Director	$0	$0	$0
MARK MEIJER	TRUSTEE	1.00	Director	$0	$0	$0
CONSTANCE CHANG	TRUSTEE	1.00	Director	$8,500	$0	$8,500
TIMOTHY MYERS	CAO / CFO	1.00	Officer	$0	$93,423	$586,323
DR JANA HALL END 03312024	CHIEF OPERATIONS OFFICER	1.00	Officer	$0	$101,074	$736,893
THOMAS CURRAN JR	GENERAL COUNSEL	1.00	Key Emp	$0	$95,143	$612,974
GERALD CALLAHAN	CHIEF STRATEGIC OFFICER	1.00	Key Emp	$0	$95,178	$603,300

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$139,332,774	$90,904,641	$2,237,961,296	$48,428,133
2024	No data	No data	No data	No data
2023	$171,827,012	$306,179,357	$2,017,682,513	$-134,352,345
2022	$175,628,938	$112,969,414	$2,082,989,471	$62,659,524
2021	$297,361,845	$70,308,987	$2,123,026,794	$227,052,858
2020	$111,524,637	$69,463,683	$1,815,971,878	$42,060,954